...
首页> 外文期刊>Microsurgery. >Biological reconstruction after resection of bone tumors of the proximal tibia using allograft shell and intramedullary free vascularized fibular graft: long-term results.
【24h】

Biological reconstruction after resection of bone tumors of the proximal tibia using allograft shell and intramedullary free vascularized fibular graft: long-term results.

机译:使用同种异体移植壳和髓内游离血管化腓骨移植物切除胫骨近端骨肿瘤后的生物重建:长期结果。

获取原文
获取原文并翻译 | 示例

摘要

Reconstruction after excision of bone tumor of the proximal tibia is a challenging issue for the reconstructive surgeon. The combined use of a free fibular flap and allograft can provide a reliable reconstructive option in this location. This article describes the authors' long-term follow-up using this technique. Twenty-seven patients that had resection of proximal tibia bone tumors underwent reconstruction using this technique. Only 21 patients that had primary reconstruction were included in this study. All patients had their surgeries performed at least 24 months before the end of the study. The average age at time of operation was 18.1 years. The average follow-up time was 139.3 months. Limb salvage was 82.7%. The average length of the resected tibial segment was 15.3 cm and that of the residual proximal tibia remaining after resection was 2.7 cm. The average time of union of fibula was 5.4 months and for union of allograft was 19.1 months. Primary union of the allograft was achieved in 90.5% of cases. Full weight-bearing was achieved at an average of 21.6 months. Ten patients (47.6%) had 14 local complications. The (MTSRS) average score at final follow-up was 27.3. Local recurrences occurred in two patients (9.5%). Distant metastasis to the lung occurred in three patients (14.3%). One patient died of disease. This technique provides good long-term results in reconstruction of proximal tibia. The viability of the fibula is a cornerstone in both success of reconstruction as well as successful management of complications.
机译:胫骨近端骨肿瘤切除后的重建对于重建外科医师而言是一个具有挑战性的问题。游离腓骨皮瓣和同种异体移植的组合使用可以在此位置提供可靠的重建选择。本文介绍了作者使用此技术的长期随访。使用该技术对27例切除了胫骨近端骨肿瘤的患者进行了重建。本研究仅包括21例原发重建患者。所有患者均在研究结束前至少24个月进行了手术。手术时的平均年龄为18.1岁。平均随访时间为139.3个月。肢体抢救率为82.7%。切除的胫骨节段的平均长度为15.3 cm,切除后残留的残余近端胫骨的平均长度为2.7 cm。腓骨联合的平均时间为5.4个月,同种异体移植的平均时间为19.1个月。 90.5%的病例实现了同种异体移植的初次联合。完全负重平均达到21.6个月。 10名患者(47.6%)有14例局部并发症。最后一次随访的(MTSRS)平均得分为27.3。两名患者(9.5%)发生局部复发。三名患者(14.3%)发生远处转移至肺部。一名病人死于疾病。该技术在重建胫骨近端方面提供了良好的长期效果。腓骨的生存能力是成功重建以及成功处理并发症的基石。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号